Pönisch, Wolfram <br/><br/>
Combined bendamustine, prednisolone and thalidomide for refractory or relapsed multiple myeloma after autologous stem-cell transplantation or conventional chemotherapy: results of a Phase I clinical trial.  [electronic resource] 

 -  British journal of haematology  Oct 2008 
 - 191-200 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1365-2141 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.2008.07076.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bendamustine Hydrochloride<br/>Combined Modality Therapy<br/>Drug Administration Schedule<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--drug therapy<br/>Nitrogen Mustard Compounds--administration & dosage<br/>Prednisolone--administration & dosage<br/>Recurrence<br/>Statistics, Nonparametric<br/>Stem Cell Transplantation--methods<br/>Survival Rate<br/>Thalidomide--administration & dosage<br/>Transplantation, Autologous